Leveraging the Active Conformation of LFA-1 As a Potential Target for Hematological Malignancies

The authors introduced a novel nano-liposomal delivery system that exploits the overexpressed, open-active conformation of Lymphocyte Function-Associated Antigen-1 (LFA-1) on malignant hematopoietic cells.